What is the share price of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) today?
The share price of JBCHEPHARM as on 29th May 2026 is ₹2167.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) share?
The past returns of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) share are- Past 1 week: -0.64%
- Past 1 month: 5.79%
- Past 3 months: 5.55%
- Past 6 months: 22.66%
- Past 1 year: 28.22%
- Past 3 years: 106.26%
- Past 5 years: 198.79%
What are the peers or stocks similar to J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM)?
The peers or stocks similar to J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) include:What is the dividend yield % of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) share?
The current dividend yield of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) is 1.02.What is the market cap of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) is ₹34799.49 Cr as of 29th May 2026.What is the 52 week high and low of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) share?
The 52-week high of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) is ₹2285.30 and the 52-week low is ₹1603.50.What is the PE and PB ratio of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) stock?
The P/E (price-to-earnings) ratio of J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) is 51.62. The P/B (price-to-book) ratio is 8.62.Which sector does J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) belong to?
J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) shares?
You can directly buy J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM Share Price
NSE₹2,167.401.67% (-36.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JBCHEPHARM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JBCHEPHARM Performance & Key Metrics
JBCHEPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 49.05 | 8.62 | 1.02% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.84 | 6.22 | 0.48% |
78%
Analysts have suggested that investors can buy this stock
from 9 analysts
Price Upside
Earnings Growth
Rev. Growth
JBCHEPHARM Company Profile
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).
SUNPHARMA
PE Ratio
37.61
37.61
1Y Return
5.85%
5.85%
Buy Reco %
93.75
93.75
TORNTPHARM
PE Ratio
69.82
69.82
1Y Return
39.53%
39.53%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
29.17
29.17
1Y Return
5.14%
5.14%
Buy Reco %
62.86
62.86
DRREDDY
PE Ratio
25.87
25.87
1Y Return
4.43%
4.43%
Buy Reco %
51.52
51.52
ZYDUSLIFE
PE Ratio
21.52
21.52
1Y Return
16.54%
16.54%
Buy Reco %
53.57
53.57
JBCHEPHARM Sentiment Analysis
JBCHEPHARM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
JBCHEPHARM Stock Summary · January 2026
The company demonstrated robust financial performance in the third quarter, achieving an 11% revenue growth to INR 1,065 crore, driven by a favorable product mix and effective cost management. While the domestic market showed signs of slowing growth, particularly in the acute gastro portfolio, the chronic segment remained strong, supporting a positive outlook for future expansion. International operations, especially in South Africa and Russia, are expected to contribute significantly, with management anticipating double-digit growth in the upcoming quarter. Strategic investments in the domestic business and a commitment to maintaining healthy EBITDA margins reflect a proactive approach to sustaining profitability. Overall, the financial outlook remains strong, bolstered by effective treasury management and a solid order book.
JBCHEPHARM Stock Growth Drivers
JBCHEPHARM Stock Growth Drivers
6Strong Financial Performance in Q3 FY '26
J.B. Pharma reported a top-line revenue growth of 11% year-on-year, reaching INR 1,065 crore. The
International Market Growth
J.B. Pharma's international operations performed well, with a 12% year-on-year revenue increase to INR 445
JBCHEPHARM Stock Challenges
JBCHEPHARM Stock Challenges
3Slowdown in Domestic Growth
The company has experienced a slowdown in domestic market growth, with the growth rate declining
Decline in Acute Gastro Portfolio
A notable decline in the acute gastro portfolio has been identified as a contributing factor
JBCHEPHARM Forecast
JBCHEPHARM Forecasts
Price
Revenue
Earnings
JBCHEPHARM Share Price Forecast
JBCHEPHARM Share Price Forecast
2026
Current
₹2,167.40
Baseline
Forecast for May 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹2,167.40
Baseline
Forecast for May 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JBCHEPHARM Company Revenue Forecast
JBCHEPHARM Company Revenue Forecast
2026
Current
₹3.95
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹3.95
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
JBCHEPHARM Stock EPS (Earnings Per Share) Forecast
JBCHEPHARM Stock EPS (Earnings Per Share) Forecast
2026
Current
₹42.63
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹42.63
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JBCHEPHARM
JBCHEPHARM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JBCHEPHARM Income Statement
JBCHEPHARM Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 851.86 | 878.36 | 1,010.29 | 1,010.57 | 971.49 | 963.96 | 1,108.49 | 1,100.24 | 1,083.00 | 916.21 | ||||||||||
Operating & Other expenses | 621.39 | 663.61 | 724.03 | 730.10 | 708.98 | 723.04 | 793.07 | 775.30 | 768.90 | 730.28 | ||||||||||
EBITDA | 230.47 | 214.75 | 286.26 | 280.47 | 262.51 | 240.92 | 315.42 | 324.94 | 314.10 | 185.93 | ||||||||||
| Depreciation/Amortization | 34.03 | 40.74 | 40.78 | 41.88 | 41.94 | 46.44 | 42.70 | 44.44 | 45.35 | 50.01 | ||||||||||
| PBIT | 196.44 | 174.01 | 245.48 | 238.59 | 220.57 | 194.48 | 272.72 | 280.50 | 268.75 | 135.92 | ||||||||||
| Interest & Other Items | 12.49 | 9.41 | 5.64 | 2.06 | 2.58 | 1.45 | 1.11 | 1.35 | 1.88 | 1.23 | ||||||||||
| PBT | 183.95 | 164.60 | 239.84 | 236.53 | 217.99 | 193.03 | 271.61 | 279.15 | 266.87 | 134.69 | ||||||||||
| Taxes & Other Items | 50.38 | 38.44 | 63.01 | 61.96 | 55.50 | 47.34 | 69.23 | 71.33 | 68.98 | 33.32 | ||||||||||
| Net Income | 133.57 | 126.16 | 176.83 | 174.57 | 162.49 | 145.69 | 202.38 | 207.82 | 197.89 | 101.37 | ||||||||||
| EPS | 8.62 | 8.22 | 11.39 | 11.24 | 10.46 | 9.36 | 12.99 | 13.29 | 12.63 | 6.35 |
JBCHEPHARM Company Updates
JBCHEPHARM Stock Peers
JBCHEPHARM Past Performance & Peer Comparison
JBCHEPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| J B Chemicals and Pharmaceuticals Ltd | 51.62 | 8.62 | 1.02% |
| Sun Pharmaceutical Industries Ltd | 37.61 | 5.96 | 0.89% |
| Torrent Pharmaceuticals Ltd | 69.82 | 19.67 | — |
| Cipla Ltd | 29.17 | 3.62 | 0.93% |
JBCHEPHARM Stock Price Comparison
Compare JBCHEPHARM with any stock or ETFCompare JBCHEPHARM with any stock or ETF
JBCHEPHARM
JBCHEPHARM Holdings
JBCHEPHARM Shareholdings
JBCHEPHARM Promoter Holdings Trend
JBCHEPHARM Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.24%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JBCHEPHARM Institutional Holdings Trend
JBCHEPHARM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.45%
JBCHEPHARM Shareholding Pattern
JBCHEPHARM Shareholding Pattern
JBCHEPHARM Shareholding History
JBCHEPHARM Shareholding History
Foreign Institutions
Mutual Funds Invested in JBCHEPHARM
Mutual Funds Invested in JBCHEPHARM
No mutual funds holding trends are available
Top 5 Mutual Funds holding J B Chemicals and Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.7812% | Percentage of the fund’s portfolio invested in the stock 1.55% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 28/68 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7234% | Percentage of the fund’s portfolio invested in the stock 2.23% | Change in the portfolio weight of the stock over the last 3 months -0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/149 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7817% | Percentage of the fund’s portfolio invested in the stock 2.08% | Change in the portfolio weight of the stock over the last 3 months -0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/97 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing JBCHEPHARM stock
smallcases containing JBCHEPHARM stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM Events
JBCHEPHARM Events
JBCHEPHARM Dividend Trend
Increasing Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JBCHEPHARM has increased dividends consistently over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.00%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.98 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JBCHEPHARM Dividend Trend
Increasing Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JBCHEPHARM has increased dividends consistently over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.00%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.98 every year
JBCHEPHARM Upcoming Dividends
JBCHEPHARM Upcoming Dividends
No upcoming dividends are available
JBCHEPHARM Past Dividends
JBCHEPHARM Past Dividends
Cash Dividend
Ex DateEx DateMay 29, 2026
Final
Final | Div/Share: ₹9.30
Dividend/Share
₹9.30
Ex DateEx Date
May 29, 2026
Cash Dividend
Ex DateEx DateFeb 11, 2026
Interim
Interim | Div/Share: ₹12.70
Dividend/Share
₹12.70
Ex DateEx Date
Feb 11, 2026
Cash Dividend
Ex DateEx DateJul 30, 2025
Final
Final | Div/Share: ₹7.00
Dividend/Share
₹7.00
Ex DateEx Date
Jul 30, 2025
Cash Dividend
Ex DateEx DateFeb 7, 2025
Interim
Interim | Div/Share: ₹8.50
Dividend/Share
₹8.50
Ex DateEx Date
Feb 7, 2025
Cash Dividend
Ex DateEx DateAug 14, 2024
Final
Final | Div/Share: ₹6.75
Dividend/Share
₹6.75
Ex DateEx Date
Aug 14, 2024
JBCHEPHARM Stock News & Opinions
JBCHEPHARM Stock News & Opinions
Articles & Videos
Corporate
Corporate
J B Chemicals & Pharmaceuticals AGM scheduledJ B Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 17 June 2026.
2 days agoCapital Market - Live
Spotlight
Spotlight
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive sessionJ B Chemicals & Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 2243.5, up 2.32% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.94% on the day, quoting at 23941.85. The Sensex is at 76196.93, up 1.04%. J B Chemicals & Pharmaceuticals Ltd has risen around 9.57% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has risen around 6.21% in last one month and is currently quoting at 24573.95, up 0.15% on the day. The volume in the stock stood at 3.63 lakh shares today, compared to the daily average of 3.09 lakh shares in last one month.The PE of the stock is 50.78 based on TTM earnings ending March 26.Powered by Capital Market - Live
4 days agoCapital Market - Live
Corporate
Corporate
Board of J B Chemicals & Pharmaceuticals recommends final dividendJ B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the final dividend of Rs 9.3 per equity Share (i.e. 930%) , subject to the approval of the shareholders.
2 weeks agoCapital Market - Live
Earnings
Earnings
J B Chemicals & Pharmaceuticals consolidated net profit declines 30.42% in the March 2026 quarterNet profit of J B Chemicals & Pharmaceuticals declined 30.42% to Rs 101.37 crore in the quarter ended March 2026 as against Rs 145.69 crore during the previous quarter ended March 2025. Sales declined 4.77% to Rs 904.23 crore in the quarter ended March 2026 as against Rs 949.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 7.56% to Rs 709.47 crore in the year ended March 2026 as against Rs 659.58 crore during the previous year ended March 2025. Sales rose 5.87% to Rs 4147.79 crore in the year ended March 2026 as against Rs 3917.99 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales904.23949.48 -5 4147.793917.99 6 OPM %22.2423.85 -26.7026.34 - PBDT211.88239.47 -12 1162.011058.43 10 PBT161.87193.03 -16 979.51887.39 10 NP101.37145.69 -30 709.47659.58 8 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Spotlight
Spotlight
J B Chemicals & Pharmaceuticals Ltd spurts 0.08%, gains for fifth straight sessionJ B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quoting at Rs 2144.9, up 0.08% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. J B Chemicals & Pharmaceuticals Ltd has gained around 8.87% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has gained around 9.02% in last one month and is currently quoting at 24135.5, down 0.02% on the day. The volume in the stock stood at 84681 shares today, compared to the daily average of 3.06 lakh shares in last one month.The PE of the stock is 47.27 based on TTM earnings ending December 25.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Spotlight
Spotlight
J B Chemicals & Pharmaceuticals Ltd up for third straight sessionJ B Chemicals & Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 2141, up 2.22% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. J B Chemicals & Pharmaceuticals Ltd has gained around 9.13% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has gained around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 2.23 lakh shares today, compared to the daily average of 3.22 lakh shares in last one month.The PE of the stock is 46.27 based on TTM earnings ending December 25.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Corporate
J B Chemicals & Pharmaceuticals to table resultsJ B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 May 2026.
3 weeks agoCapital Market - Live
Corporate
Corporate
J B Chemicals & Pharmaceuticals to hold EGMJ B Chemicals & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 April 2026.
1 month agoCapital Market - Live
Spotlight
Spotlight
J B Chemicals & Pharmaceuticals Ltd gains for fifth sessionJ B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2081.4, up 0.53% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.31% on the day, quoting at 25504.3. The Sensex is at 82333.07, up 0.13%. J B Chemicals & Pharmaceuticals Ltd has added around 10.86% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has added around 5.55% in last one month and is currently quoting at 22632.05, up 1.62% on the day. The volume in the stock stood at 86468 shares today, compared to the daily average of 3.2 lakh shares in last one month.The PE of the stock is 45.69 based on TTM earnings ending December 25.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Spotlight
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive sessionJ B Chemicals & Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 2032.7, up 1.62% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 25662.7. The Sensex is at 83141.63, up 0.39%. J B Chemicals & Pharmaceuticals Ltd has risen around 8.27% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has risen around 3.27% in last one month and is currently quoting at 22452.4, up 0.21% on the day. The volume in the stock stood at 2.34 lakh shares today, compared to the daily average of 2.97 lakh shares in last one month.The PE of the stock is 44.18 based on TTM earnings ending December 25.Powered by Capital Market - Live
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.36%, vs industry avg of 9.86%
Over the last 5 years, market share increased from 0.66% to 0.89%
Over the last 5 years, net income has grown at a yearly rate of 19.47%, vs industry avg of 19.71%